Bioextrax AB

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0016276752
SEK
2.00
0.06 (3.09%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Biovica International AB
Intervacc AB
Xintela AB
Alligator Bioscience AB
AlzeCure Pharma AB
Mendus AB
Bio-Works Technologies AB
Active Biotech AB
SenzaGen AB
Bioextrax AB
Toleranzia AB
Why is Bioextrax AB ?
Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report
Verdict Report
Icon
No Data Found
Is Bioextrax AB for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Bioextrax AB
-47.94%
-1.21
73.75%
OMX Stockholm 30
8.01%
0.51
18.11%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
13.09%
EBIT Growth (5y)
-212.05%
EBIT to Interest (avg)
-16.26
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.64
Sales to Capital Employed (avg)
0.06
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
7.03
EV to EBIT
-6.58
EV to EBITDA
-7.07
EV to Capital Employed
17.61
EV to Sales
108.39
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-267.47%
ROE (Latest)
-94.61%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company
OPERATING CASH FLOW(Y)

Highest at SEK -18.19 MM

NET PROFIT(HY)

Higher at SEK -7.92 MM

EPS(Q)

Highest at SEK -0.1

-9What is not working for the Company
NET SALES(HY)

At SEK 0.2 MM has Grown at -75.19%

RAW MATERIAL COST(Y)

Grown by 511,519% (YoY

Here's what is working for Bioextrax AB
Net Profit
Higher at SEK -7.92 MM
than preceding 12 month period ended Mar 2025
MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (SEK MM)

Operating Cash Flow
Highest at SEK -18.19 MM
in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (SEK MM)

EPS
Highest at SEK -0.1
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (SEK)

Here's what is not working for Bioextrax AB
Net Sales
At SEK 0.2 MM has Grown at -75.19%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very negative

Net Sales (SEK MM)

Raw Material Cost
Grown by 511,519% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales